Jianqiang Cai - Concepedia

Author

Jianqiang Cai

Chinese Academy of Medical Sciences & Peking Union Medical College

Also Known As

Cai Jianqiang, Cai, Jianqiang, Jian-Qiang Cai, Jian-qiang Cai, Jianqiang Cai, Jian‐Qiang Cai, Yefan Zhang

101

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College Sun Yat-sen University Sun Yat-sen University Cancer Center Peking Union Medical College Hospital Peking University

About

Jianqiang Cai is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, hepatology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	2.1K
2	Health Sciences	4	4	392
3	Business	1	1	22
4	Engineering	1	1	22
5	Natural Sciences	1	1	421

Jianqiang Cai

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro, The Lancet Oncology Surgical OncologyHepatologyMedicineSurgeryLiver Cancer	2015	1.1K
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) Jian Zhou, Hui‐Chuan Sun, Zheng Wang, Liver Cancer	2020	813
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma Meng Li, Hong Zhao, Laura D. Wood, Nature Genetics ChromatinTumor BiologyChromatin StructureGene Arid2Chromatin Remodeling	2011	421
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma Yihebali Chi, Zhiwei Fang, Xiaonan Hong, Clinical Cancer Research	2018	322
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy Chunfeng Qu, Yuting Wang, Pei Wang, Proceedings of the National Academy of Sciences Asymptomatic Hbsag-seropositive IndividualsPathologyHepatic DisordersViral HepatitisBioanalysis	2019	174
Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma Weilong Zhang, Huan He, Mengya Zang, Gastroenterology	2017	171
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway Hong Zhao, Yuming Guo, Shu Li, Oncotarget	2015	150
AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma Qing Zhu, Yarui Ma, Junbo Liang, Signal Transduction and Targeted Therapy	2021	117
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) Juxian Sun, Xinyu Bi, Mengchao Wu, Liver Cancer PathologyCirrhosisAutoimmune Liver DiseaseHepatic DisordersPvtt Treatment	2022	103
Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center Minjie Wang, Yuting Wang, Xiaoshuang Feng, International Journal of Infectious Diseases Hepatitis DHepatologyHepatitis CHepatitis C VirusViral Hepatitis	2017	93

Page 1